We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Corteva's Q3 Earnings on the Horizon: Key Insights for Investors
Read MoreHide Full Article
Key Takeaways
CTVA's Seed segment may gain from premium genetics demand, value-based pricing and licensing growth.
CTVA's Crop Protection business may benefit from newer products, manufacturing efficiencies and lower costs.
Pricing pressure, weak farm economics, dry weather and separation costs may weigh on CTVA's Q3 profitability.
Corteva, Inc. (CTVA - Free Report) is set to unveil its third-quarter fiscal 2026 results on Nov. 11, after market close. Investors are eager to see if the company can beat market expectations. The Zacks Consensus Estimate for revenues is pegged at $1.8 billion, implying a 32.5% decline from the prior year.
Meanwhile, the consensus mark for earnings per share has been steady at 9 cents in the past seven days, suggesting 139.1% growth from the year-ago period. CTVA has a trailing four-quarter earnings surprise of 21.9%, on average.
Corteva's third-quarter 2026 performance is likely to have benefited from continued demand for advanced seed technologies and differentiated product portfolio. Farmers' focus on improving crop yields and productivity is likely to have supported demand for premium genetics. The company's value-based pricing strategy, growing licensing business and solid market position in Brazil are also likely to have supported the Seed segment's performance.
The Crop Protection segment is likely to have benefited from continued adoption of newer products and healthy demand for differentiated crop protection solutions. Meanwhile, ongoing productivity initiatives, manufacturing efficiencies, lower input costs and disciplined cost management are likely to have supported operational performance and helped cushion the impact of competitive pricing pressures.
However, persistent pricing pressure in the Crop Protection market, particularly in Brazil, might have weighed on Corteva's third-quarter performance. Intense competition in a well-supplied market and generic competition for certain off-patent products are likely to have constrained pricing. Management also highlighted weakness in pre-emergent herbicide pricing. Additionally, dry weather conditions in Europe and parts of the United States might have affected fungicide applications, limiting demand.
Corteva's performance might also have been affected by challenging farm economics and seasonal demand patterns. Tight credit conditions in Brazil, alongside elevated fuel and fertilizer costs, have been pressuring farmers' margins and encouraging delayed purchasing decisions. Meanwhile, higher logistics and freight expenses, separation-related dis-synergies and geopolitical uncertainties are likely to have added cost pressures. Management also indicated that the timing of Safrinha sales and separation expenses might have weighed on third-quarter profitability.
What the Zacks Model Says About CTVA’s Q3 Earnings
Our proven model does not conclusively predict an earnings beat for CTVA this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. However, that’s not the case here.
CTVA has an Earnings ESP of 0.00% and a Zacks Rank #5 (Strong Sell). You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks With Favorable Combination
Here are three other companies you may also want to consider, as our model shows that these too have the right combination of elements to post an earnings beat this season:
BJ’s Wholesale Club Holdings, Inc. (BJ - Free Report) has an Earnings ESP of +2.54% and currently carries a Zacks Rank of 2. The Zacks Consensus Estimate for third-quarter fiscal 2026 earnings per share is pegged at 1.22 cents, implying 5.2% year-over-year growth. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for quarterly revenues is pegged at $5.9 billion, which indicates an increase of 11.1% from the figure reported in the prior-year quarter. BJ has a trailing four-quarter earnings surprise of 4.8%, on average.
SharkNinja, Inc. (SN - Free Report) currently has an Earnings ESP of +0.79% and a Zacks Rank of 2. The Zacks Consensus Estimate for third-quarter fiscal 2027 earnings per share is pegged at $1.89, implying 26% year-over-year growth.
The Zacks Consensus Estimate for quarterly revenues is pegged at $1.9 billion, which indicates growth of 14.4% from the figure reported in the prior-year quarter. SN has a trailing four-quarter earnings surprise of 11.4%, on average.
General Mills, Inc. (GIS - Free Report) has an Earnings ESP of +0.26% and currently carries a Zacks Rank of 3. The Zacks Consensus Estimate for second-quarter fiscal 2027 earnings per share is pegged at 96 cents, implying a 12.7% year-over-year decline.
The Zacks Consensus Estimate for quarterly revenues is pegged at $4.7 billion, which indicates a decrease of 2.8% from the figure reported in the prior-year quarter. GIS has a trailing four-quarter earnings surprise of 4.8%, on average.
View the Zacks #1 Rank List
Image: Bigstock
Corteva's Q3 Earnings on the Horizon: Key Insights for Investors
Key Takeaways
Corteva, Inc. (CTVA - Free Report) is set to unveil its third-quarter fiscal 2026 results on Nov. 11, after market close. Investors are eager to see if the company can beat market expectations. The Zacks Consensus Estimate for revenues is pegged at $1.8 billion, implying a 32.5% decline from the prior year.
Meanwhile, the consensus mark for earnings per share has been steady at 9 cents in the past seven days, suggesting 139.1% growth from the year-ago period. CTVA has a trailing four-quarter earnings surprise of 21.9%, on average.
Corteva, Inc. Price, Consensus and EPS Surprise
Corteva, Inc. price-consensus-eps-surprise-chart | Corteva, Inc. Quote
Key Factors to Observe for CTVA's Q3 Earnings
Corteva's third-quarter 2026 performance is likely to have benefited from continued demand for advanced seed technologies and differentiated product portfolio. Farmers' focus on improving crop yields and productivity is likely to have supported demand for premium genetics. The company's value-based pricing strategy, growing licensing business and solid market position in Brazil are also likely to have supported the Seed segment's performance.
The Crop Protection segment is likely to have benefited from continued adoption of newer products and healthy demand for differentiated crop protection solutions. Meanwhile, ongoing productivity initiatives, manufacturing efficiencies, lower input costs and disciplined cost management are likely to have supported operational performance and helped cushion the impact of competitive pricing pressures.
However, persistent pricing pressure in the Crop Protection market, particularly in Brazil, might have weighed on Corteva's third-quarter performance. Intense competition in a well-supplied market and generic competition for certain off-patent products are likely to have constrained pricing. Management also highlighted weakness in pre-emergent herbicide pricing. Additionally, dry weather conditions in Europe and parts of the United States might have affected fungicide applications, limiting demand.
Corteva's performance might also have been affected by challenging farm economics and seasonal demand patterns. Tight credit conditions in Brazil, alongside elevated fuel and fertilizer costs, have been pressuring farmers' margins and encouraging delayed purchasing decisions. Meanwhile, higher logistics and freight expenses, separation-related dis-synergies and geopolitical uncertainties are likely to have added cost pressures. Management also indicated that the timing of Safrinha sales and separation expenses might have weighed on third-quarter profitability.
What the Zacks Model Says About CTVA’s Q3 Earnings
Our proven model does not conclusively predict an earnings beat for CTVA this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. However, that’s not the case here.
CTVA has an Earnings ESP of 0.00% and a Zacks Rank #5 (Strong Sell). You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks With Favorable Combination
Here are three other companies you may also want to consider, as our model shows that these too have the right combination of elements to post an earnings beat this season:
BJ’s Wholesale Club Holdings, Inc. (BJ - Free Report) has an Earnings ESP of +2.54% and currently carries a Zacks Rank of 2. The Zacks Consensus Estimate for third-quarter fiscal 2026 earnings per share is pegged at 1.22 cents, implying 5.2% year-over-year growth. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for quarterly revenues is pegged at $5.9 billion, which indicates an increase of 11.1% from the figure reported in the prior-year quarter. BJ has a trailing four-quarter earnings surprise of 4.8%, on average.
SharkNinja, Inc. (SN - Free Report) currently has an Earnings ESP of +0.79% and a Zacks Rank of 2. The Zacks Consensus Estimate for third-quarter fiscal 2027 earnings per share is pegged at $1.89, implying 26% year-over-year growth.
The Zacks Consensus Estimate for quarterly revenues is pegged at $1.9 billion, which indicates growth of 14.4% from the figure reported in the prior-year quarter. SN has a trailing four-quarter earnings surprise of 11.4%, on average.
General Mills, Inc. (GIS - Free Report) has an Earnings ESP of +0.26% and currently carries a Zacks Rank of 3. The Zacks Consensus Estimate for second-quarter fiscal 2027 earnings per share is pegged at 96 cents, implying a 12.7% year-over-year decline.
The Zacks Consensus Estimate for quarterly revenues is pegged at $4.7 billion, which indicates a decrease of 2.8% from the figure reported in the prior-year quarter. GIS has a trailing four-quarter earnings surprise of 4.8%, on average.